Rangering i aksjer
#29054
PT Indofarma Tbk, along with its affiliated entities, is dedicated to the... PT Indofarma Tbk, along with its affiliated entities, is dedicated to the production and marketing of pharmaceutical goods across Indonesia. The company's activities encompass the commerce and supply of a diverse range of items, including medications, medical equipment, healthcare provisions, various extracts, and herbal products. It also operates its own laboratory facilities and provides specific COVID-19 diagnostic services, such as rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), and Genose tests. Additionally, the firm engages in the export of its merchandise. Established in 1918, Indofarma Tbk maintains its primary operations in Bekasi, Indonesia. Historically, the company was known as PT Indofarma (Persero) Tbk and now functions as a subsidiary of PT. Bio Farma.
Aksjekurs
$0.00748841
Sist synkronisert: 2024-07-01
Handel PT Indofarma Tbk (INAF)
Pris INAF pris med markedsverdi på B
Markedsverdi av PT Indofarma Tbk(INAF)
Markedsverdi: $23.21M
Per August 2026 har PT Indofarma Tbk en markedsverdi på $23.21M. Dette gjør PT Indofarma Tbk til det 29054th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for PT Indofarma Tbk fra 2001 til 2026
INAF sammenlignet med topp 5 mest populære stocks
| Pris på INAF |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.323T
|
+22,937,151.76%
|
|
|
|
|
$4.621T
|
+19,909,140.79%
|
|
|
|
|
$4.138T
|
+17,829,351.11%
|
|
|
|
|
$3.593T
|
+15,480,921.12%
|
|
|
|
|
$2.840T
|
+12,236,522.84%
|
